Mittal, N.K.; Mandal, B.; Balabathula, P.; Setua, S.; Janagam, D.R.; Lothstein, L.; Thoma, L.A.; Wood, G.C.
Formulation, Development, and In Vitro Evaluation of a CD22 Targeted Liposomal System Containing a Non-Cardiotoxic Anthracycline for B Cell Malignancies. Pharmaceutics 2018, 10, 50.
https://doi.org/10.3390/pharmaceutics10020050
AMA Style
Mittal NK, Mandal B, Balabathula P, Setua S, Janagam DR, Lothstein L, Thoma LA, Wood GC.
Formulation, Development, and In Vitro Evaluation of a CD22 Targeted Liposomal System Containing a Non-Cardiotoxic Anthracycline for B Cell Malignancies. Pharmaceutics. 2018; 10(2):50.
https://doi.org/10.3390/pharmaceutics10020050
Chicago/Turabian Style
Mittal, Nivesh K., Bivash Mandal, Pavan Balabathula, Saini Setua, Dileep R. Janagam, Leonard Lothstein, Laura A. Thoma, and George C. Wood.
2018. "Formulation, Development, and In Vitro Evaluation of a CD22 Targeted Liposomal System Containing a Non-Cardiotoxic Anthracycline for B Cell Malignancies" Pharmaceutics 10, no. 2: 50.
https://doi.org/10.3390/pharmaceutics10020050
APA Style
Mittal, N. K., Mandal, B., Balabathula, P., Setua, S., Janagam, D. R., Lothstein, L., Thoma, L. A., & Wood, G. C.
(2018). Formulation, Development, and In Vitro Evaluation of a CD22 Targeted Liposomal System Containing a Non-Cardiotoxic Anthracycline for B Cell Malignancies. Pharmaceutics, 10(2), 50.
https://doi.org/10.3390/pharmaceutics10020050